Journal of Pharmaceutical Research最新文献

筛选
英文 中文
Semibarbula orientalis (Web.) Wijk. and Marg: A Potential Source of Bioactive and High Value Phytochemicals 东方半倒刺(网页)Wijk。和Marg:生物活性和高价值植物化学物质的潜在来源
Journal of Pharmaceutical Research Pub Date : 2021-06-12 DOI: 10.9734/JPRI/2021/V33I31B31688
Vinod Deora, G. Deora
{"title":"Semibarbula orientalis (Web.) Wijk. and Marg: A Potential Source of Bioactive and High Value Phytochemicals","authors":"Vinod Deora, G. Deora","doi":"10.9734/JPRI/2021/V33I31B31688","DOIUrl":"https://doi.org/10.9734/JPRI/2021/V33I31B31688","url":null,"abstract":"Aims: Present study aims to evaluate the presence of bioactive compounds of Semibarbula orientalis (Pottiales: Pottiaceae), a bryophyte whole plant methanolic extract by Gas Chromatography-Mass Spectrometry (GC-MS) which are important medicinally as well flavouring and colouring agents. Study design: Qualitative preliminary phytochemical and GC-MS analysis. Place and duration of study: The study was carried out at Department of Botany, Center of Advanced Study, Jai Narain Vyas University, Jodhpur-Rajasthan (India) from January 2017 to December 2020. Methodology: The Preliminary phytochemical screening of S.orientalis was carried out qualitatively following the standard methods of Harbourne, Trease and Evans. GC-MS analysis was performed by GC-MS-QP 2010 Shimadzu, Japan equipped with thermal desorption system TD 20. Results: Preliminary phytochemical analysis revealed the presence of carbohydrates, proteins, phenols, sterols, flavonoids and terpenoids. GC-MS analysis of methanolic extract of whole plant Original Research Article Deora and Deora.; JPRI, 33(31B): 34-43, 2021; Article no.JPRI.69374 35 revealed the presence of 49 bioactive phytoconstituents which include mainly n-Hexadecanoic acid, Cis-vaccenic acid, Azulene, Hexadecanoic acid metyl ester, 1,3-Propanediol, 2-(hydroxyl methyl)-2-nitro, 9-12 Octadecadienol chloride (z,z), Octadecanoic acid etc. Conclusion: Preliminary phytochemical and GC-MS profiling of methanolic extract Semibarbula orientalis whole plant showed the presence of high value bioactive compounds with important medicinal properties and other uses in food industries as flavouring and colouring agents.","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45432568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atlanta Classification for Acute Pancreatitis- A Study Protocol 急性胰腺炎亚特兰大分类-研究方案
Journal of Pharmaceutical Research Pub Date : 2021-06-12 DOI: 10.9734/JPRI/2021/V33I31B31691
V. K. Singh, R. Dhande, G. Mishra
{"title":"Atlanta Classification for Acute Pancreatitis- A Study Protocol","authors":"V. K. Singh, R. Dhande, G. Mishra","doi":"10.9734/JPRI/2021/V33I31B31691","DOIUrl":"https://doi.org/10.9734/JPRI/2021/V33I31B31691","url":null,"abstract":"Background: Acute pancreatitis is one of the most common abdominal pathologies having variable outcome ranging from self limiting abdominal pain to high mortality and morbidity due to organ failure, over the past five decades, various classification systems have emerged to classify pancreatitis according to its severity , and the associated complications have emerged to classify acute pancreatitis and its various complications, such as Apache Scoring , Ct Severity , Modified Ct Severity ,Ransen and Atlanta Classification. Objectives: We in our study will be classifying patients suffering from acute pancreatitis according to the revised Atlanta classification to divide them into interstitial edematous pancreatitis and necrotizing pancreatitis. The local complications will be classified according to CT imaging findings into acute necrotic collection, psuedocyst, acute necrotic collection and walled of necrosis. Organ failure will be assessed according to modified marshal scoring system into transient or persistent organ failure. Methodology: We will be carrying forward our study on Siemens 16 slice computer tomography machine over a sample of 140 patients coming to the outpatient department of our hospital which will be followed by a routine clinical follow up of the patient to find out their prognosis. Study Protocol Singh et al.; JPRI, 33(31B): 61-68, 2021; Article no.JPRI.68602 62 Results: Will be tabulated at the end of the study using SPSS version 26 software. Conclusion: The revised Atlanta classification for acute pancreatitis, in conjunction with the Modified Marshall Scoring System for organ failure, if found useful, in our series in improving the prognosis of the patients, then it can be incorporated in management.","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41972344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical Development, Standardization and Clinical Evaluation of Efficacy of a Polyherbal Hair-Pack and Hair Gel in Dandruff Control 多草药发包和发胶控制头皮屑疗效的药物开发、标准化和临床评价
Journal of Pharmaceutical Research Pub Date : 2021-06-12 DOI: 10.9734/JPRI/2021/V33I31B31692
Poonam Madan, B. Rathi, Renu Rathi, S. Wairagade, D. Zade
{"title":"Pharmaceutical Development, Standardization and Clinical Evaluation of Efficacy of a Polyherbal Hair-Pack and Hair Gel in Dandruff Control","authors":"Poonam Madan, B. Rathi, Renu Rathi, S. Wairagade, D. Zade","doi":"10.9734/JPRI/2021/V33I31B31692","DOIUrl":"https://doi.org/10.9734/JPRI/2021/V33I31B31692","url":null,"abstract":"Introduction: Dandruff is a commonly found hair problem affecting all age groups with high recurrence and is considered a social stigma. In Ayurved it is compared with Darunak falling under the category of kshudrarogadhikar and is caused due to the vitiation of vaat and kapha. Traditionally the treatment comprises of application of oil, steaming, applying packs, washing of hair etc. According to modern science dandruff is a non-treatable disease condition which is prevented by use of anti-dandruff shampoos, creams and hair masks. The available products are expensive and results are not very satisfactory and recurrence is common. Currently treatment available for dandruff is found to be expensive with unsatisfactory results in terms of recurrence of symptoms. \u0000Aim and objective: Pharmaceutical development, standardization and clinical evaluation of efficacy of a polyherbal Hair pack and Hair gel in dandruff  control \u0000Materials and methods: Hair pack will be made with selected drugs like Amalki, Bibhitaki, Haritaki, Japa, Yashtimadhu, Musta, Brahmi and it will be converted into gel form. Analytical study for standardization of powder and gel dosage form will be done. Clinical evaluation of both dosage forms for efficacy will be done. \u0000Observations and results: Observation will be done on the basis of photographic evaluation of the condition of pre and post severity of symptoms and duration of recurrence time of dandruff will be noted. Results will be drawn on the basis of observations and applying suitable tests. It will be noted and presented in form of table, charts, graphs etc. \u0000Conclusion: Currently available treatment for dandruff does not provide complete remission of symptoms for long duration and it is very expensive too. Thus the newly designed herbal formulation is aimed to provide significant result in controlling dandruff and its associated symptoms and modified dosage i.e. gel will overcome the limitation of powder and provide a cost effective cosmetic product in controlling dandruff.","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41418145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Role of Green Tea on Obesity and Type-II Diabetes Mellitus Male Individuals 绿茶对肥胖和2型糖尿病男性个体的作用
Journal of Pharmaceutical Research Pub Date : 2021-06-11 DOI: 10.9734/JPRI/2021/V33I31A31679
Tazeen Shah, S. Dars, Saima Sheikh, F. Shaikh, S. Ansari, N. Akhtar, Arslan Ahmer
{"title":"Role of Green Tea on Obesity and Type-II Diabetes Mellitus Male Individuals","authors":"Tazeen Shah, S. Dars, Saima Sheikh, F. Shaikh, S. Ansari, N. Akhtar, Arslan Ahmer","doi":"10.9734/JPRI/2021/V33I31A31679","DOIUrl":"https://doi.org/10.9734/JPRI/2021/V33I31A31679","url":null,"abstract":"Objective: To evaluate the effects of Green tea on obesity and hyperglycemia. Methodology: This observational study was carried out at the department of physiology, in affiliation to Medical Research Centre Liaquat University of Medical and Health Sciences Jamshoro. The sample was collected by convenient random sampling. Total 100 participants, 50 controls and 50 obese diabetics were enrolled. Informed written consent was taken from participants. The body mass index (BMI) of the participants was taken at the time of recruitment, Original Research Article Shah et al.; JPRI, 33(31A): 183-187, 2021; Article no.JPRI.69895","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48121702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pharmaceutico-Analytical Study of Muktashukti Pishti and Muktashukti bhasma and Comparative Evaluation of their Relative Oral Bioavailability 牡丹、牡丹的药理分析研究及相对口服生物利用度比较评价
Journal of Pharmaceutical Research Pub Date : 2021-06-11 DOI: 10.9734/JPRI/2021/V33I31B31680
S. Kamble, A. Wanjari, B. Rathi, D. Rajput
{"title":"Pharmaceutico-Analytical Study of Muktashukti Pishti and Muktashukti bhasma and Comparative Evaluation of their Relative Oral Bioavailability","authors":"S. Kamble, A. Wanjari, B. Rathi, D. Rajput","doi":"10.9734/JPRI/2021/V33I31B31680","DOIUrl":"https://doi.org/10.9734/JPRI/2021/V33I31B31680","url":null,"abstract":"Background: Shukti (Oyster) is a very commonly occurring calcium form. It is rich source of calcium & minerals. As per text it can be converted into two forms which are bhasma (calcinated ash) and pishti (powdered form without agni).These forms may have different rate of absorption. This needs to be studied. Aim: To study Pharmaceutico-analytical study of Muktashukti pishti & Muktashukti bhasma and comparative evaluation of their relative oral bioavailability. Materials and methods: The two formulations will be prepared from shukti (oyster). By triturating with Gulabjala Muktashukti pishti will be prepared and by traditional puta method Muktashukti bhasma will be prepared. The prepared formulations will be assessed for Bhasma Pariksha mentioned in Ayurveda. Organoleptic characters, physicochemical parameters and Particle size distribution analysis, SEM-EDX (Scanning Electron Microscopy, Energy Dispersive X-Ray Analysis), FTIR (Fourier-transform infrared spectroscopy), XRD (X-Ray Diffraction), GCMS (Gas Study Protocol Kamble et al.; JPRI, 33(31B): 1-9, 2021; Article no.JPRI.68599 2 Chromatography Mass Spectrometry) will be evaluated. To assess the relative oral bioavailability of Muktashukti pishti & Muktashukti bhasma study will be conducted in healthy volunteers and will be compared with the standard calcium supplement. The study will be conducted in between two test groups and standard group. Observation and results: The analytical parameters will be assessed and compared in Muktashukti bhasma and Muktashukti pishti. For relative oral bioavailability Blood serum calcium will be assessed in all three groups. By applying unpaired “t” Test, One-way ANOVA the statistical significance can be measured. Conclusion: The pharmaceutical & analytical study of Muktashukti pishti and Muktashukti bhasma will provide the standard parameters and clinical comparative evaluation with standard will generate evidence for better bioavailability.","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45819505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
A Validated Reversed-Phase HPLC Analytical Method for the Analysis of Rosuvastatin Calcium in Bulk Drug and Tablet Dosage Formulation 反相高效液相色谱法测定原料药和片剂中瑞舒伐他汀钙的含量
Journal of Pharmaceutical Research Pub Date : 2021-06-11 DOI: 10.9734/JPRI/2021/V33I31A31677
A. Pimpale, R. Kakde
{"title":"A Validated Reversed-Phase HPLC Analytical Method for the Analysis of Rosuvastatin Calcium in Bulk Drug and Tablet Dosage Formulation","authors":"A. Pimpale, R. Kakde","doi":"10.9734/JPRI/2021/V33I31A31677","DOIUrl":"https://doi.org/10.9734/JPRI/2021/V33I31A31677","url":null,"abstract":"Aims: The current research work has desired the validated reversed-phase analytical technique for the assurance of rosuvastatin calcium in bulk and tablet formulation. Study design: Experimental research work. Place and duration of study: UDPS, RTM Nagpur University, Nagpur, Maharashtra State, India between June 2019 and March 2020. Methodology: The segregation was obtained on a reversed-phase Princeton (C18) column with dimensions (250mm × 4.6mm, 5μ). The solvent system employed was a mixture of buffer, and methanol in the proportion (20:80) v/v, flow rate one ml per minute. Detection wavelength at 240 nm. The retention time (RT)beneath the developed chromatographic condition was found to be 2.848 minutes for rosuvastatin calcium. Results: The technique indicates linearity within the range of 2-16 μg per ml with a correlation Original Research Article Pimpale and Kakde; JPRI, 33(31A): 164-171, 2021; Article no.JPRI.68217 165 coefficient (r) is 0.9999. The analysis of marketed tablet formulations was erect to be 99.98%. The percentage RSD was ˂2% and % recovery was found to be 97.94-100.37%. Conclusion: The advanced reversed-phase HPLC technique was erect to be simple, specific, linear, sensitive, rapid, accurate, precise, economical, and can be utilized for daily quality control of rosuvastatin calcium in tablet and bulk formulations.","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41727252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phytopharmacological Assessment of Some Medicinal Plants of Thal Desert of Pakistan 巴基斯坦塔尔沙漠部分药用植物的植物药理学评价
Journal of Pharmaceutical Research Pub Date : 2021-06-11 DOI: 10.9734/JPRI/2021/V33I31A31687
Zunair Khalid, G. Yasin, A. Altaf, Syeda Amna Batool, Asma Kanwal, Sobia Sohail
{"title":"Phytopharmacological Assessment of Some Medicinal Plants of Thal Desert of Pakistan","authors":"Zunair Khalid, G. Yasin, A. Altaf, Syeda Amna Batool, Asma Kanwal, Sobia Sohail","doi":"10.9734/JPRI/2021/V33I31A31687","DOIUrl":"https://doi.org/10.9734/JPRI/2021/V33I31A31687","url":null,"abstract":"The presence of secondary metabolites and various ions in a plant determines its phytophamacological potential. Desert plants are adapted to stressful environmet by synthesizing secondary metabolites and ions accumulation as osmoticum.The present study was conducted to evaluate the pharmacological potential of Thal desert plants in term of their metabolites and nutrient ions concentrations. Five specimens of seasonally available herbs and three of trees of Thal desert plants were colected. After collection specimens were analysed for alkaloids, terpenoids, tannins, sugar and ion contents. The data were analyzed statistically and means were compared by Duncan’s Multiple Range Test. Among the herbs Panicum antidotale root showed highest terpenoid, K ion and Ca ion contents. The herb Aerva javanica stem showed lowest alkaloid, tannin, soluble sugar, phosphorus, potassium and calcium contents. Among trees specimens, Tamarix aphylla leaves showed highest soluble sugar, phosphorous, potassium and calcium contents. Stem of Acacia modesta showed the lowest alkaloid, terpenoid, phosphorous and potassium contents. Original Research Article Khalid et al.; JPRI, 33(31A): 217-226, 2021; Article no.JPRI.69790","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47332052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical Characteristics of Urogenital Fistulas in PMCH Nawabshah: A Cross-sectional Study PMCH Nawabshah患者泌尿生殖道瘘的临床特征:横断面研究
Journal of Pharmaceutical Research Pub Date : 2021-06-11 DOI: 10.9734/JPRI/2021/V33I31A31676
Aneela Tehzeen, Hazooran Lakhan, S. Awan, M. Rani, Shahida Baloch, M. Suhail, Arslan Ahmer
{"title":"Clinical Characteristics of Urogenital Fistulas in PMCH Nawabshah: A Cross-sectional Study","authors":"Aneela Tehzeen, Hazooran Lakhan, S. Awan, M. Rani, Shahida Baloch, M. Suhail, Arslan Ahmer","doi":"10.9734/JPRI/2021/V33I31A31676","DOIUrl":"https://doi.org/10.9734/JPRI/2021/V33I31A31676","url":null,"abstract":"Objective: To analyze the clinical characteristics of urogenital fistulas reported at PMCH Nawabshah. Methodology: A cross-sectional study, concluded in three years from January 2018 to December, 2020 in all ages patients with urogenital fistulas (UGF). The referred cases of UGF to gynecology and Urology Departments of the PMCH Nawabshah. The females with UGF results after elective Original Research Article Tehzeen et al.; JPRI, 33(31A): 157-163, 2021; Article no.JPRI.69823 158 caesarean section and gynecologic surgery including hysterectomy, prolapse repair and myomectomy were included whereas patients with UGF results due to other operative measures which includes emergency caesarian section, traumatic and congenital were excluded from this study. The data were analyzed thru SPSS version 22.0. Results: Total 247 patients were included in present study. The age of patients were 20 years to 66 years with mean age 38.99+SD7.992. Frequency and percentages of different variables that were included in this study were for the demographic and co morbidities. Majority of patients were from rural setup, house wives having low education profile, belonging to low socioeconomically and educational status. DM and HTN were the common co-morbidities observed in study population. The different frequencies and percentages were calculated for the different surgical procedure adopted before the development of fistulas, UVF and OF was assessed in different procedures. Hysterectomies was most common surgical procedure than C/S and others. P value was statistically insignificant here 0.696. Wound infections were also seen in post operated cases with high ratios due to contaminations; wound infection was present in 20.6% cases, which was very high. Conclusion: Present study revealed that the many of urogenital fistulas treated and repaired patients at our hospital setup, associated with iatrogenic obstetric origin and no any patients of UGF associated with obstructed laboras it is contrasting with other developing countries. Recorded fistulas were cured after the first surgical repair.","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45998382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Characterization of Pioglitazone Nanoparticles for the Effective Treatment of Diabetes Mellitus 吡格列酮纳米颗粒有效治疗糖尿病的研制与表征
Journal of Pharmaceutical Research Pub Date : 2021-06-11 DOI: 10.9734/JPRI/2021/V33I31A31678
Revathi A. Gupta, P. O. Kumar
{"title":"Development and Characterization of Pioglitazone Nanoparticles for the Effective Treatment of Diabetes Mellitus","authors":"Revathi A. Gupta, P. O. Kumar","doi":"10.9734/JPRI/2021/V33I31A31678","DOIUrl":"https://doi.org/10.9734/JPRI/2021/V33I31A31678","url":null,"abstract":"Pioglitazone is designated as a BCS class II medication since it is weakly water soluble.The goal of this study was to create starch nanoparticles for the administration of Pioglitazone in attempt to lessen dose-related side effects and maybe prolong its release in the treatment of diabetes.Using starch as a polymer, tween 80 as a stearic barrier, and citric acid to enhance stability, nanoparticles were constructed using the solvent evaporation technique. In-vitro characterization techniques for drug-polymer compatibility, size, surface morphology, encapsulation efficacy, and delivery properties were performed on framed nanoparticles, followed by In-vivo studies.The compatible nature of selected excipients for the manufacture of Pioglitazone nanoparticles was shown by FTIR findings.The results of the XRD analysis revealed that the generated Pioglitazone nanoparticles were non-crystalline in nature.The selected developed Pioglitazone nanoparticles were in cubic phase with average particle size of 160.5 ± 11.24–245.4 ± 15.96 nm with charge ranging from 10.5 ± 6.21-138.6 ± 5.31mV.The encapsulation efficiency of Pioglitazone nanoparticles produced ranged from 57.24 5.80 to 89.96 1.9%. The In-vitro drug release studies of Pioglitazone nanoparticles showed controlled drug release profile. Furthermore, In-vivo investigations on blood glucose profiles revealed that the created Pioglitazone nanoparticles for the treatment of diabetes mellitus had a substantial effect. Original Research Article Gupta and Odayakumar; JPRI, 33(31A): 172-182, 2021; Article no.JPRI.69332 173","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41359253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Performance of IHI Global Trigger Tool in Identification of Adverse Drug Events: A Prospective Observational Study IHI全球触发工具在药物不良事件识别中的性能评估:一项前瞻性观察研究
Journal of Pharmaceutical Research Pub Date : 2021-06-11 DOI: 10.9734/JPRI/2021/V33I31A31675
Narayana Goruntla, Krishna Yasaswini Nitturi, Krishnapriya Pujari, L. Jayanthi, V. R. Gurram, K. Veerabhadrappa, Pradeepkumar Bhupalam
{"title":"Evaluation of Performance of IHI Global Trigger Tool in Identification of Adverse Drug Events: A Prospective Observational Study","authors":"Narayana Goruntla, Krishna Yasaswini Nitturi, Krishnapriya Pujari, L. Jayanthi, V. R. Gurram, K. Veerabhadrappa, Pradeepkumar Bhupalam","doi":"10.9734/JPRI/2021/V33I31A31675","DOIUrl":"https://doi.org/10.9734/JPRI/2021/V33I31A31675","url":null,"abstract":"Aims: The study aims to evaluate the performance of the Institute for Healthcare Improvement (IHI) global trigger tool in the identification of adverse drug events. Study design: Prospective observational study. Place and duration of study: The study was conducted in a General Medicine department of a Original research Article Goruntla et al.; JPRI, 33(31A): 146-156, 2021; Article no.JPRI.69737 147 secondary care referral hospital located in rural, resource-limited settings of Bathalapalli, Anantapur district, Andhra Pradesh, India. The study was conducted for a period of six months, from June 2019 to November 2019. Methodology: A pre-designed data collection form was used to collect the data from the study participants. The required data was obtained from the patient case sheet, lab reports, treatment charts, daily nursing notes, daily physician notes, and direct patient interviews. The global trigger tool developed by IHI was used for the rapid review of inpatient medical records and to generate clues for the identification of ADEs. Descriptive statistics were used to represent the findings of demographics, clinical characteristics, ADE profiles, IHI triggers, and clinical alterations. ADE incidence was shown in a measure of ADE per 1000 patient days. IHI global trigger tool performance in detecting ADE was measured by sensitivity, specificity, positive predictive value, and negative predictive value. Results: A total of 192 patients were enrolled in the study. Among them, 225 triggers and 123 ADEs were detected. The incidence of ADEs in the inpatients estimated by the IHI method was estimated as; 20.2 ADEs per 1000 patient days,64.0ADEs per 100 admissions, 56.2percent of admissions with ADE. Majority of ADEs are shown possible relationship with drug (60; 48.7%), level-2 severity (49; 39.8%), and not preventable (52; 42.2%). Most IHI global triggers showed high sensitivity, specificity, positive predictive value, and negative predictive value for detecting ADEs. Conclusion: The study shows that most of the triggers in the IHI Trigger tool have shown good accuracy in identifying ADEs. Thus, using the IHI Trigger Tool to identify ADEs can help to improve patient safety. Therefore, the study recommends incorporating IHI global trigger tool in routine, conventional ADE screening techniques to improve the detection rate and promote drug safety.","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47045941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信